Early experiences of SARS-CoV-2 infection in severe asthmatics receiving biologic therapy
- PMID: 32592790
- PMCID: PMC7313481
- DOI: 10.1016/j.jaip.2020.06.027
Early experiences of SARS-CoV-2 infection in severe asthmatics receiving biologic therapy
Comment on
-
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27. Allergy. 2020. PMID: 32077115
References
-
- Vos T., Abajobir A.A., Abate K.H., Abbafati C., Abbas K.M., Abd-Allah F. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–1259. - PMC - PubMed
-
- Zhang J.J., Dong X., Cao Y.Y., Yuan Y.D., Yang Y.B., Yan Y.Q. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75:1730–1741. - PubMed
-
- Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous